Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-10-25
DOI
10.1111/1346-8138.15655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
- (2019) Stefan Schreiber et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriasis treat to target: defining outcomes in psoriasis using data from a real world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
- (2019) S.K. Mahil et al. BRITISH JOURNAL OF DERMATOLOGY
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
- (2018) Andrew Blauvelt et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Old and New Biological Therapies for Psoriasis
- (2017) Kirsten Rønholt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research
- (2017) Toshihiro Ito et al. JOURNAL OF DERMATOLOGY
- Prevalence and current therapies of psoriatic arthritis in Japan: A survey by the Japanese Society of Psoriasis Research in 2016
- (2017) Toshiyuki Yamamoto et al. JOURNAL OF DERMATOLOGY
- Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice
- (2017) Dafna D. Gladman et al. JOURNAL OF RHEUMATOLOGY
- The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events
- (2017) Alexander Egeberg et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
- (2017) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
- (2017) Zheng Zhang et al. BMJ Open
- Prevalence and Clinical Characteristics of Psoriatic Arthritis in Japan
- (2015) Y. Ohara et al. JOURNAL OF RHEUMATOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- The Epidemiology of Psoriatic Arthritis
- (2015) Alexis Ogdie et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
- (2014) Philip J. Mease et al. DRUGS
- Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study
- (2014) Mamitaro Ohtsuki et al. JOURNAL OF DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
- (2009) T. KOIKE et al. JOURNAL OF RHEUMATOLOGY
- The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab
- (2008) Kristian Reich et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now